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ABSTRACT
The ubiquitous occurrence of pharmaceuticals and personal care products
(PPCPs) in aquatic environments has raised concerns about potential adverse
effects on aquatic ecology and human health. Certain pharmaceuticals have
recently become a major focus of research to better understand the routes and
persistence of these compounds once they enter into aquatic system.
In this research, two model compounds were selected to represent
pharmaceuticals that have been identified by recent research as being persistent;
specifically, these compounds were trimethoprim (TMP, a basic antibiotic) and
gemfibrozil (GEM, an acidic lipid regulator). Treatment of synthetic wastewater
that contained these drugs was accomplished using wet-air oxidation (WAO). Preand post-treatment drug concentrations were determined by reversed-phase liquid
chromatography. The influences of different operational conditions on removal
efficiency of the drugs by WAO were evaluated, namely reaction time, initial drug
concentration, oxygen concentration, and the amount and composition of additional
organic matter used during WAO. The optimum removal efficiencies were found to
be 91.9 % for TMP and 95.5 % for GEM.
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CHAPTER 1 INTRODUCTION
1.1 WASTEWATER
Water is indispensable for all forms of life. It is needed in almost all of
human activities. The world’s population is growing by approximately 80 million
people a year, implying an increase in freshwater demand of about 64 billion cubic
meters a year (UNESCO 2009). The rapid increase in population and the increased
demand for domestic, industrial, and agricultural establishments to meet human
requirements have created problems such as overexploitation of available natural
resources, leading to pollution of the land, air and water environments (Pokhrel
and Viraraghavan 2004). Today, the topic of wastewater causes great concerns to
both the public and researchers. This Chapter is separated into three parts, mainly
to introduce the current context of water scarcity, the sources that result in water
scarcity, and the related treatment technologies that are helping to reduce and solve
the water scarcity issues.
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1.1.1 WATER SCARCITY
Approximately 71% of the earth’s surface is covered by water. However, a
small fraction (0.014%) of the world’s total water supply is readily available
freshwater (Shiklomanov 1998, Tsuchida, Tamanoi and Murota 1984). Water is a
renewable resource, but in many parts of the world, water resources have become
so depleted or contaminated that they are unable to meet an ever-increasing
demand. The challenges are more acutely felt in developing countries where 95%
of the world’s new population is born each year (UNEPFI, SIWI 2005). Thus,
water scarcity is currently an issue attracting attention worldwide, especially in
regions where renewable water is limited (Table 1.1).
Because of the scarcity of water in many regions of the world exist, a host
of problems, like socio-economic, environmental, and political conflicts/issues
have resulted. In addition to these concerns, the lack of safe water is also the
leading cause of disease, hunger and poverty in the developing world today. Right
now, countless communities in over 50 nations are suffering because local water
supplies are scarce, contaminated, or non-existent (MICATZ 2013).
A 2008 report by the World Health Organization indicated that more than
3.4 million people died each year from water, sanitation, and hygiene-related
causes. Nearly all the deaths (99 %) occurred in the developing world (WHO
2008). For comparison, this is equivalent to almost the entire population in the city
of Los Angeles in the United States. In addition, tens of thousands of people die
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Country

Population
1995
(million)

Algeria
Bahrain
Barbados
Burundi
Cape
Verde
Comoros
Cyprus
Egypt
Ethiopia
Haiti
Iran
Israel
Jordan
Kenya
Kuwait
Libya
Malawi
Malta

28.1
0.6
0.3
6.1
0.4

Water per
capital
1995
m3/year
527
161
192
594
777

0.6
0.7
62.1
56.4
7.1
68.4
5.5
5.4
27.2
1.7
5.4
9.7
0.4

1667
1208
936
1950
1544
1719
389
318
1112
95
111
1933
82

Population Water per
2025
capital
(million)
2025
(million)
47.3
313
0.9
104
0.3
169
12.3
292
0.7
442
1.3
1.0
65.8
136.3
12.5
128.3
8.0
11.9
50.2
2.9
12.9
20.4
0.4

760
947
607
807
879
916
270
144
602
55
47
917
71

% Growth
rate of
population
1998
2.4
2.0
0.5
2.5
2.9
2.7
0.7
2.2
2.5
2.1
1.8
1.5
2.5
2.0
2.3
3.7
1.7
0.6

Table 1.1 Population size and growth and renewable freshwater availability in waterscarce countries, 1995 and 2025 (Egelioglu and Agboola 2012)
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from causes directly related to contaminated water, and for those who survive,
without good health, there is little chance for a normal and productive life (Project
Humanity 2013). Throughout the world, water supplies in developing countries are
contaminated with a wide variety of micro-organisms including viruses, bacteria
and protozoans that cause typhoid, diarrheal diseases, amoebic dysentery, cholera,
and other notoriously virulent diseases. Diarrhea is the most important public
health concern that is directly related to water and sanitation. About 4 billion cases
of diarrhea per year cause 1.8 million deaths, over 90 per cent of them (1.6
million) among children under five. Repeated episodes of diarrheal disease make
children more vulnerable to other diseases and malnutrition (UNICEF 2003).
Unfortunately, there has been a dramatic increase in the past 10 years of the
number of deaths from the consumption of contaminated drinking water around
the world.

1.1.2 WASTEWATER SOURCE
An understanding of the nature of wastewater is important for the
appropriate design of wastewater treatment plants and the effective selection of
treatment technologies. Wastewater originates predominantly from water usage by
residences, commercial and industrial establishments, together with groundwater,
surface water and storm water.
The growing public awareness of the fate of the pollutants and stringent
regulations established by the various governmental authorities such as provincial
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and federal agencies are forcing the industry to treat effluents to the required
compliance levels before discharging the treated water to the environment
(Padmapriya, Murugesan and Dhamotharan 2012). However, improperly disposed
effluents from some industries still cause slime growth, thermal impacts, color
problems, scum formation, and loss of aesthetic beauty in the environment
(Schmidt and Kannenberg 1998). They also increase the amount of toxic
substances in the water, causing death to the zooplankton and fish, as well as
profoundly affecting the terrestrial ecosystem.
The Organization for Economic Cooperation and Development reported in
2001 that within the industrialized countries, the chemical industry was the single
largest consumer of water (43%) followed by metals processing (26%), pulp and
paper (11%), with other uses (20%) (Environmental Outlook for the Chemicals
Industry 2009). Critical sources of water pollution include chlorine for water
treatment in pulp and paper processing, semi-conductor manufacturing,
photographic processing, pharmaceutical manufacturing, textile dying and
cleaning, and processes as varied as metals. Several types of industries that are
supposed to help improve the quality of life for humans are at the same time,
discharging wastes from their processes that have now been identified as
problematic groups of pollutants.

A. Pulp And Paper Processing
Wood consists of two primary components: cellulose and lignin. Pulping is
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the process depending on the systematic separation of lignin from cellulose. The
Kraft and sulphite process are the two significant chemical processes for pulp and
paper industry to separating these two components (EPA 1997). During the
biodegradation process, the use of a limited suite of enzymes: ligninase, glyoxal
oxidase, and Mn peroxidase are needed. To achieve the same oxidation of these
compounds, for which nature uses only oxygen, industry has substituted chlorine
compounds, resulting in the release of phenoloic compounds and environmentally
persistent organo-chorine compounds (Hjeresen 2001).
In Canada, the pulp and paper industry accounts for a major portion of the
country's economy in terms of value of production, but on the other hand, it is
responsible for 50% of all wastes dumped into Canada's waters (Environment
Canada 2012).

B. Textile And Dyeing Industry
Dye wastes are often rich in color and can be easily identified by the
human eye. They contain residues of reactive dyes and chemicals, such as complex
components, many aerosols, much more hard-degradation materials that result in a
high chemical oxygen demand (COD) and biochemical oxygen demand (BOD)
(Wang, et al. 2011). At present, most dyes are mainly heterocyclic, aromatic
compounds, and color-display groups, which structure are more complicated and
stable, thus, resulting in greater difficulty to treat effluent from printing and dyeing
operation (Ding, Li and Wang 2010).
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With the increasing demands of human consumption, the textile and dyeing
industries consume large volumes of water, and thus produce large quantities of
wastewater from different steps in the dyeing processes. According to the report,
the textile and dyeing industries in China produced about 70 billion tons of
wastewater each year, which required proper treatment before being released into
the environment (State Environmental Protection Administration 2010).

C. Pharmaceuticals Manufacturing
Pharmaceutical companies are devoted to discovering and developing new
medicines that will enable patients to live longer, healthier and more productive
lives. But at the same time, they generate both hazardous and non-hazardous
wastes, and the insufficient treatment of these wastes leads to surface and
groundwater contamination that poses risks to the health of the aquatic ecosystems
and the surrounding environment (Zorita, Martensson and Matthiasson 2009).
The pharmaceutical compounds reach the aquatic environment as effluents
of the hospital structures, pharmaceutical industries, municipal sewage treatment
plants, as well as residues of their use in agriculture and breeding (Nikolaou, Meric
and Fatta 2007). Several investigations have shown evidence that some substances
of pharmaceutical are detectable in the environment with concentration levels up
to the µg /L due to incompletely removal during conventional wastewater
treatments (Gòmez, et al. 2007, Comoretto and Chiron 2005).
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Presently, the effects of pharmaceutical wastes on aquatic organisms are
the apparent major concern, including inhibition of growth, production of stress
hormone (abscisic acid), feminization and behavioral changes (Ngwuluka 2011).
Furthermore, ibuprofen, fluoxethin and ciprofloxacin have been shown to cause
mortality of fish in the µg/L range (Richards 2004).

1.1.3 WASTEWATER TREATMENT TECHNOLOGIES
Because water shortage is an ever increasing concern, a solution to increase
the water availability and quality for several uses can be the reuse of sewage
treatment plants effluents. Before the 1880s, people began to realize that the
understanding and developing effective wastewater treatment technology was
significant for human being’s healthy lives and was environmentally important. In
1899, the first wastewater treatment plant was set up and located near Yahara
River at East Washington Avenue Madison, WI (Madison Metropolitan Sewerage
District 2004). Over the past ten decades, the concern over increasing needs for
drinking water and awareness for development of systems to improve water
quality have provided incentives to develop new innovations and technologies and
improve performance of existing technologies.
The general components in wastewater treatment processes could be
categorized as physical, chemical and biological unit operations. Table 1.2 lists the
unit operations included within each category. In order to achieve different levels
of contaminant removal, individual wastewater treatment procedures are combined
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into a variety of systems, classified as primary, secondary, and tertiary wastewater
treatment. Normally, physical processes are used initially followed by chemical
processes, like precipitation if needed. In sewage treatment plants, biological
methods are generally the primary method for the treatment.

Physical unit operation

Screening
Comminution
Flow equalization
Sedimentation
Flotation
Filtration

Chemical unit operation

Chemical precipitation
Adsorption
Disinfection
Dechlorination
Oxidation
Photocatalysis
Other chemical applications

Biological unit operation

Activated sludge process
Aerated lagoon
Trickling filters
Rotating biological
Pond
stabilization
contactors
Anaerobic digestion
Biological nutrient removal

Table 1.2 Wastewater treatment unit operations and processes (United Nations 2003)
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This section mainly summarizes various conventional and advanced
physical and chemical technologies in current use and explains how they are
applied for the effective treatment of municipal wastewater.

A. Physical Operations
The main aim of physical treatment process in a water treatment system is
to protect the main treatment systems from possible damage or clogging. Various
processes are used to remove large floating and suspended material. The three
widely used types of physical unit operations are described (Ramalho 1977).
i. Screening
Screening, one of the oldest treatment methods, is employed for removing
gross pollutants from the waste stream to protect downstream equipment from
damage and avoid interference with plant operations.
ii. Sedimentation
Sedimentation, a fundamental and widely used unit operation in
wastewater treatment, is utilized to separated suspend solids from wastewaters.
Removal by sedimentation is based on the difference between densities of solids
and wastewater due to gravity.
iii. Flotation
Flotation is a process used to separate lower density solids or liquid
particles from a liquid phase by introducing gas bubbles into the liquid phase. The
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significant advantage of flotation over others is that very small or light particles
can be removed more completely and in a shorter time.

B. Chemical Operations
Chemical processes used in wastewater treatment are designed to alter the
compounds in the wastes by chemical reactions. This section mainly discusses the
chemical unit processes, including chemical precipitation, adsorption, disinfection
and other applications.
i. Chemical Precipitation
In this method, chemicals are added to the wastewater, converting
undesired soluble substances into an insoluble precipitate that can be removed.
Chemical coagulation of raw wastewater before sedimentation increase the
removal efficiency, and it has a greater feasibility of using higher overflow rates.
When removing the BOD from plain sedimentation, the reported removal
percentages was only 25-40%, while for the prepared chemical precipitation, it
increased up to 90% (WEF 1992).
ii. Adsorption
In wastewater treatment, adsorption with activated carbon aims to remove a
portion of the remaining dissolved organic matters. Activated carbon has a unique
property that is highly porous over a broad range of pore sizes from visible cracks
to crevices of molecular dimensions. Intermolecular attractions in these smallest
pores result in adsorption forces, which causes the adsorption of solutes from
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solution into these molecular scale pores. The two most common types of activated
carbon were granular activated carbon, which had a diameter greater than 0.1 mm,
and powdered activated carbon, which had a diameter of less than 0.074 mm
(Metcalf and Eddy 1991).
iii. Disinfection
Disinfection refers to the selective destruction of any pathogens, including
viruses, bacteria such as Escherichia coli, Campylobacter and Shigella, and other
Cryptosporidia, which pass through some water filters (Tansel 2008). This process
is important in drinking water treatment. Traditional disinfection processes, such
as chlorination and ozonation, are widely used in wastewater treatment plants
(Pablos, et al. 2013). However, the most notable disadvantage of this technique is
that disinfection produces chlorinated and brominated disinfection by-products
with potential carcinogenic effects on mammals (Ikehata, Naghashkar and Gamal
El-Din 2006).
iv. Other Chemical Applications
In addition to the chemical processes described above, various other
applications are necessarily encountered in wastewater treatment. Dechlorination
is the removal of free and total combined chlorine residues from chlorinated
wastewater effluent. Wet-air oxidation treats wastewater in the presence of oxygen
at a high temperature under high pressure to oxidize and decompose oxidizable
substances. Ion exchange systems can exchange ions according to an equilibrium
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reaction, which helps the softening or demineralization of water for industrial use
(Tansel 2008).

1.1.4 SUMMARY
Water is life, it is an essential substance for living systems. However, the
growing global crisis in water resources provides an important illustration of the
influence of upstream pollution prevention. For the past decade, a large amount of
patents applications for water and wastewater treatment were developed and have
addressed improvements for reliability and maintainability and improved water
quality, including the physical, chemical and biological technologies.
With the rapid increase in population and the increased demand to meet
human requirements, new technological advancements are still needed to improve
water quality. In the near future, with the advancements in materials science, nano
technology, and information technology, it is likely that there will be new
developments in the area of disinfection, oxidation methods, ion exchange resins,
sorption technologies, and advanced biological methods such as membranes
filtration and anaerobic digestion.
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1.2 WET-AIR OXIDATION
Given the vast quantities of hazardous wastewater production from
industrial and domestic activities, it is not surprising that environmental concerns
have focused research on the development of efficient wastewater treatment
technologies. Wet-air oxidation (WAO) is considered an emergent technology that
can effectively treat organic wastewaters in order to meet the progressively more
stringent environmental regulations.
As an established technology, WAO is useful for the treatment of
hazardous, toxic, and non-biodegradable waste streams, without emissions of NOx,
SO2, HCl, dioxins, furans and fly ash (Luck, Wet air oxidation: past, present and
future 1999). Therefore, this technique has potential to help reduce the world’s
water scarcity issue.
WAO has more than 80 years of commercial history. It originally
developed in the 1930s as a process to produce artificial vanilla by wet-air
oxidation of lingo sulphonic acids. It was patented as a waste treatment process in
1950 (Chemical Materiel Agency 2000). WAO was employed as an alternative
method to treat special black liquors from paper mills. Because of their very high
silica content, the usual evaporation and combustion method (Kraft process) was
unsuitable (Zimmermann 1954). Since then, applications for the wet-air oxidation
process had become as various as its history was long. For example, it has received
significant interest as a means of removing organics from refineries and acidic
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material from industrial plants as well as for pretreating sewage sludge (SIEMENS
2011, Chauzy, et al. 2010, Luck, Djafer, et al. 1999).

1.2.1 SYSTEM OVERVIEW
Wet-air oxidation is an aqueous phase oxidation process that uses
molecular oxygen contained in air (or any other oxygen containing gas) as an
oxidant. The process operates at elevated temperatures (120-320 °C) and pressures
(110-3,000 psi) (Claude, Robert and Brandenburg 1994).
The typical wet-air oxidation system uses equipment to raise the feed
stream and air (or oxygen) to the required operating pressure. This process is
applicable for aqueous waste streams, which are too dilute to incinerate and
sometimes too concentrated for biological treatment. Residence times may range
from 15 to 120 min, and the COD removal may generally be about 75–90% (Luck,
1999).
The basic flow schematic of a wet-air oxidation system is provided in
Figure 1.1. It consists of a high-pressure pump, an air or oxygen compressor, a
heat exchanger as well as a reactor with a relief valve and a downstream separator.
The wastewater or feed liquor is first pressurized by high pressure feed
pumps. In most case, a gas stream, containing sufficient oxygen to meet the
oxygen demand requirements, is injected into the pressurized waste stream. Heat
exchangers are routinely employed to preheat the feed/air mixture. When the
mixture reaches the required reaction temperature, the mixture remains in the
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reactor for a sufficient period of time to allow the oxidation reaction to approach
the design reduction in chemical oxygen demand. Since the oxidation reaction is
exothermic, producing a temperature rise in the reactor, this allows the wet-air
oxidation system to operate without any additional heat input. After heating the
reactor feed, the reactor effluent usually requires further cooling before discharge.
The final step is to reduce the pressure of the reactor effluent stream and separate
the vapor and liquid. The liquid is finally discharged for other treatments, if
needed (Claude, Robert and Brandenburg 1994).
The primary variables in the design of a wet-air oxidation system are
significant for the effective application of an integrated process. These variables
includes:
•

Reactor Temperature

•

Reactor Pressure

•

Reaction Retention Time

•

Initial Oxygen Pressure (which is obtained from initial air pressure)
Of these variables, temperature is most sensitive factor for the degree of

oxidation (Mishra, Mahajani and Joshi 1995). This is because WAO is known to
follow a free-radical mechanism. The chemical bond’s breaking is under the direct
influence of the reaction temperature (Bachir, et al. 1998). Higher temperatures
will provide enough energy to break chemical bonds. To a certain extent, the more
the reaction temperature is raised, the more efficient the breakage of the bonds is.
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Figure 1.1 Flow diagram of a wet-air oxidation process
(Luck, Wet air oxidation: past, present and future 1999).
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The system is pressurized to control vaporization of the liguid water, thus
maintaining the water in a sub-critical state. The reactor pressure is also a function
of reactor temperature. As temperature and initial air pressure are increased, the
required system operating pressure will also increase. The phase boundary
between liquid and gas does not continue indefinitely. Instead, it terminates at a
point called the critical point. This reflects the fact that, at extremely high
temperatures and pressures, the liquid and gaseous phases become
indistinguishable (Papon, Leblond and Meijer 1999). For the WAO conditions,
they mainly stay in the liquid phase.
For the reaction retention time, 45-90 minutes are typical of wet-air
oxidation system designs with operating temperatures above 150°C (302°F). At
lower operating temperatures, longer retention times are typically required.

1.2.2 WET-AIR OXIDATION MECHANISM
The WAO process converts organic compounds into carbon dioxide, water
and biodegradable, short-chain organic acids. Inorganic constituents such as
sulfides and cyanides can also be oxidized. The wet-air oxidation process can
involve any or all of the following reactions (Eftaxias, et al. 2001):
𝑂𝑟𝑔𝑎𝑛𝑖𝑐𝑠 + 𝑂! → 𝐶𝑂! + 𝐻! 𝑂 + 𝑅𝐶𝑂𝑂𝐻∗
𝑆𝑢𝑙𝑓𝑢𝑟  𝑆𝑝𝑒𝑐𝑖𝑒𝑠 + 𝑂! → 𝑆𝑂!!!
𝑂𝑟𝑔𝑎𝑛𝑖𝑐  𝐶𝑙 + 𝑂! → 𝐶𝑙 ! + 𝐶𝑂! + 𝑅𝐶𝑂𝑂𝐻∗
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𝑂𝑟𝑔𝑎𝑛  𝑖𝑐  𝑁 + 𝑂! → 𝑁𝐻! + 𝐶𝑂! + 𝑅𝐶𝑂𝑂𝐻∗
𝑃ℎ𝑜𝑠𝑝ℎ𝑜𝑟𝑢𝑠 + 𝑂! → 𝑃𝑂!!!
*Short chain organic acids such as acetic acid and formic acid make up the major
fraction of residual organic compounds
Catalytic wet-air oxidation (CWAO) has been shown to be an effective
technique for eliminating organic compounds, such as phenol (Levec 1997).
Nowadays, phenol and its derivatives have received great attentions, because
phenol commonly appears in aqueous effluents from sources such as
petrochemical, chemical and pharmaceutical industries (Fortuny, et al. 1999).
Phenolic wastewaters are considered refractory in conventional bio-treatments
because of their bactericidal properties (Autenrieth 1991). Hence, phenolic
compounds must be specifically targeted for removal by subsequent treatment in
conventional sewage plants.
The complete oxidation of phenol into carbon dioxide and water follows an
extremely complex pathway composed by parallel and consecutive reactions. In
1999, (Fortuny, et al. 1999) did an exhaustive analysis of the stream containing
intermediates by a validated reversed-phase liquid chromatographic (RPLC)
protocol. The analyses showed the main partial oxidation products to be light
carboxylic acids such as oxalic, acetic and formic. Malonic, maleic and its isomer,
fumaric acid, were also detected in trace amounts. Over 50 different reaction
models have been proposed, Eftaxias summarized many of the related reactions,
and a simplified reaction network is shown in Figure 1.2.
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Figure 1.2 Simplified reaction pathway for catalytic wet-air oxidation of phenol
(Eftaxias, et al. 2001)

	
  

20

1.2.3 WET-AIR OXIDATION INDUSTRIAL APPLICATIONS
As a well-established technique for wastewater treatment, WAO has been
used operationally for treatment of toxic, highly organic wastewater and sludge
worldwide since 1950s. The wet-oxidation reaction generally takes place between
100°C and 372°C at elevated pressures to maintain water in the liquid phase.
Depending on its different industrial applications, the temperature ranges can be
subdivided into low (100-200°C), medium (200-260°C), and high temperature
(260-320°C) operation. The typical non-catalytic WAO waste treatment
applications are listed below according to required reaction temperature (Maugans
and Ellis 2002):
•

Low temperature oxidation (100-200°C) includes the low pressure thermal
conditioning of sludge and low strength sulfides typically found in spent
caustic waste streams. Other industrial wastes including cyanide and
phosphorus as well as non-chlorinated pesticides could also been treated by
low temperature oxidation.

•

Medium temperature (200-260°C) oxidation is used for typical ethylene
spent caustics, as well as for autothermal thermal sludge conditioning
(TSC), and some industrial wastes.

•

High temperature (260-320°C) oxidation is used for refinery spent caustic,
sludge destruction, and most WAO treated industrial wastewaters.
The spent caustic treatment and sludge treatment and destruction are two

types of the key historic and commercial WAO applications currently.
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A. Spent Caustic Treatment
One of the most common industrial applications for the wet-air oxidation
process is treatment of spent caustic wastewater streams generated by ethylene
plants and refineries. Due to the high levels of sulfides, the waste stream can create
odor and safety problems when liberated as a gas, and other problems associated
with discharge to a plant's wastewater treatment plant (Claude, Robert and
Brandenburg 1994). The WAO process is used for complete oxidation to eliminate
or reduce sulfur species such as sulfides and mercaptans, and other complex
organic contaminants such as phenols prior to discharge to a conventional
biological treatment process.
In 1995, a WAO system was put into operation for treatment of refinery
spent caustic at the Refinaria de Petroleos de Manguinhos, S.A. (RPDM) in Rio de
Janeiro (Carlos and Maugans 2000). As Table 1.3 shows, in this system,
approximately 80% destruction of COD is achieved, with near complete phenols
destruction and sulfide levels reduced to below detection limits.

B. Sludge Treatment and Destruction
Nowadays, major cities are facing a common challenge dealing with sludge
disposal. Therefore, the wet-air oxidation process has another widespread
application that is for treatment of municipal sludge. The majority of these
systems are low temperature and pressure designs, commonly referred to as low
pressure oxidation (LPO). An LPO system operates at 175-200°C (350-395°F) and
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Reactor Inset

Reactor Effluent

72,000

15,000

COD reduction

--

79.2%

BOD/COD

--

0.515

Phenols (mg/L)

1,700

3

Sulfide (mg/L)

2,700

<1*

Mercaptans (mg/L)

2,800

2

Thiosulfate (mg/L)

640

<26*

13.43

8.24

COD (mg/L)

pH

Table 1.3 RPDM spent caustic WAO performance (T=246°C) (Carlos and Maugans 2000)

200-500 psi. Under these conditions, sludge/water mixtures are allowed to drain
more effectively, thus to be broken down to become the mixtures that have better
dewaterability (SIEMENS 2011). The final products are then dewatered and dried
to over 90% solids content, prior to being disposed as a cover product for landfills.
When higher temperature and pressure is applied, destruction of volatile solids
occurs and wet-air oxidation can be used for sludge destruction, a possible
alternative to incineration.
The Athos™ Process (Luck, Djafer, et al. 1999) is a wet-oxidation system
dedicated for oxidation of residual sludge from municipal wastewater treatment
facilities. It was installed at the North Brussels Waste Water Treatment Plant
(WWTP) and started-up in 2007. With homogeneous copper (II) ion as the catalyst
and pure oxygen as the oxidative agent, 75 to 90% COD mineralization is
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achieved and a solids volume reduction of 90 to 95% can be achieved (Chauzy, et
al. 2010).

1.2.4 SUMMARY
Wet-air oxidation is very attractive among the various types of wastewater
treatment processes that are used for treating aqueous wastes polluted with organic
matter. The basic idea of the process is to enhance contact between molecular
oxygen and the organic matter to be oxidized at the condition 120-320°C for
temperature, 110-3,000 psi for pressure. The WAO treatment process has been
developed over many years and has been applied to a wide variety of waste
treatment industrial projects, including spent caustic treatment, sludge treatment
and destruction, production of vanillin and treatment of industrial wastewaters.
Because of the utilization of direct chemical oxidation process and its high
thermal efficiency, WAO offers us an environmental wastewater treatment. And
additional applications will surely be realized as more stringent discharge criteria
are applied by regulatory agencies

1.3 PHARMACEUTICAL CONCERNS
Pharmaceutical drugs are chemicals used for diagnosis, treatment, or
prevention of illness of the human body and parts of pharmaceuticals could control
symptoms instead of cure conditions. During the most recent decades, tons of
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pharmacologically active substances were used annually in both human medicine
for preventing illness and animal and fish farming as growth promoters or
parasiticides (Diaz-Cruz, Alda and Barcelo 2003).
With the addition of new pharmaceuticals to the already large array of
chemical classes, most of these substances are excreted un-metabolized or as
active metabolites entering the environment (Halling-Sorensen, et al. 1998).
Indeed, pharmaceutical compounds have been detected in sewage treatment plant
effluents, surface and ground water and even in drinking water all over the world
(Mompelat, Le and Thomas 2009) (Mompelat, Le and Thomas 2009) (Xu, et al.
2007) (Brown, et al. 2006) (D.W.Kolpin, et al. 2002) (Golet, Alder and Giger
2002). Figure1.3 shows the main sources and routes of drugs in the environment.
The principal way is through the discharge of raw and treated sewage from
residential users or medical facilities. Even though advanced treatment processes
are able to achieve higher removal rates, they still do not obtain complete removal
of pharmaceuticals (Mompelat, Le and Thomas 2009) (Stackelberg, et al. 2007).
After all these various discharge routes and subsequent treatment of wastewater,
very low ng/L concentrations of pharmaceuticals have been detected in drinking
water supplies (Jelic, Petrovic and Barcelo 2012).
Even through the amount of pharmaceuticals and their bioactive
metabolites being disposed or discharged into the environment are probably low,
their continual input into the environment may lead to a long-term, unnoticed
.
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Figure 1.3 Principal routes of environmental exposure to drugs consumed
in human and veterinary medicine (Khetan and Collins 2007)
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adverse effect on both aquatic and terrestrial organisms (Diaz-Cruz, Alda and
Barcelo 2003)

1.3.1 ANTIBIOTIC RESIDUES IN ENVIRONMENT
Thousands of different drugs are approved for use throughout the world in
human and veterinary medicine. Antibiotics, a group of pharmaceuticals, are
administered to human, livestock and poultry, and fish to treat diseases and
infections every year (Schneider 1994, Eckman 1994, Migliore, et al. 1997). The
increasing use of these drugs during the last six decades has caused matters of
great concern. Table 1.4 provides some data on the consumption of antibiotics in
different cities of European Union countries.

-France: 34 tons (1999); 33 tons (2001)
-Italy: 25 tons (1999); 27 tons (2001)
Human*
-Spain: 22 tons (1999); 19 tons (2001)
-Germany: 14 tons (1999); 13 tons (2001)
Veterinary

-EU 1,600 tons (1999)

* Values expresses in Defined Daily Dose per 1,000 inhabitants per day (D/D).
Table 1.4 Consumption of antibiotics in human and veterinary medicine
(Diaz-Cruz, Alda and Barcelo 2003)
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Indeed, the widespread use of antibiotics, coupled with their subsequent
release into the environment, merit a great concern. Recent research showed that
the amount of different antibiotics residues discharged to environment is
increasing year by year (Xu, et al. 2007) (Brown, et al. 2006) (D.W.Kolpin, et al.
2002) (Golet, Alder and Giger 2002). These antibiotic contaminants might lead to
altered microbial community structures in nature, accelerate the proliferation of
antibiotic-resistant pathogens. What is worse, this can also pose threats to human
health and result in some related diseases, such as thrombocytopenia,
hyperkalemia and shiga toxin (Daughton and Ternes 1999). Thus, a better
understanding of the occurrence and fate of antibiotics and engineered water
systems is essential to assess, reduce and eliminate the risks of these compounds.

1.3.2 TRIMETHOPRIM
Trimethoprim (TMP) is among the most important antibacterial agents
used in human and veterinary medicine worldwide for long years. It is mainly used
in the prophylaxis and the treatment of urinary tract infection by selectively
inhibiting the bacterial species of the dihydrofolate reductase enzyme (Hitching,
Kuyper and Baccananari 1988). It is also used in combination with other drugs to
treat certain types of pneumonia and traveler's diarrhea. Figure 1.4 is the structure
of TMP and its properties are listed in Table 1.5.
TMP has been reported as one of the antibiotics most frequently detected in
municipal wastewaters (vary by several hundred ng L-1) and surface waters (ten to
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several hundred ng L-1) (Ho, et al. 2011). Another study has summarized the
worldwide presence of TMP residues in water sources: at 0.6–7.6 µg/L level in
hospital sewage water in Sweden, at 0.12 and 0.16 µg/L levels in wastewater
effluents from East Aurora and Holland, respectively, 12.4 mg/kg level in manure
and soil in a German farming area, at 40–705 ng/L in two municipal wastewater
treatment plants in USA, and 0.013–0.15 µg/L in US streams (Bekçi, Seki and
Yurdakoc 2006).
When trimethoprim reaches into the environmental systems, there are
multiple routes for their possible removal, including physical-degradation, photodegradation, bio-degradation and several types of chemical oxidation degradations.
A summary of the removal treatments of trimethoprim that have been evaluated in
recent five years follows.

A. Adsorbents
Adsorption is an effective method in removing suspended solids, odors,
organic matter, and oil from aqueous solutions due to its low cost, simplicity of
design, ease of operation, and insensitivity to toxic substances (Low, et al. 2011).
A great variety of versatile adsorbents are used at present for the removal of
pollutants from wastewater, including silica gel, alumina, activated carbons, and
synthetic exchange resins.
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Figure 1.4 The structure of trimethoprim

Properties
IUPAC Systematic Name

5-(3,4,5- trimethoxybenzyl)
pyrimidine- 2,4- diamine

Molecular formula

C14H18N4O3

CAS

738-70-5

Molecular weight

290.3

Water Solubility

0.4 mg/ml

Melting point

199-203 °C

Storage temperature

2-8 °C

pKa values

1.32 ; 7.12
Table 1.5 Properties of trimethoprim

(Ho, et al. 2011, Cao 1995, Roth and Strelitz 1969)
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Bekçi et al. investigated montmorillonite KSF and K10 as adsorbent in the
removal of trimethoprim, respectively in 2006 (Bekçi, Seki and Yurdakoc 2006)
and 2007 (Bekçi, Seki and Yurdakoc 2007). Both of these adsorbents provided
high surface area, high adsorption capacity and mechanical stability. Through
observing the interaction between these two montmorillonites and TMP, the
researchers found that the adsorptive removal of TMP from aqueous solution was
pH dependent. In the range of pH 2.5 and 6.3, adsorption was increased via the
attraction between the negatively charged surface of clay and protonated form of
the drug. Beyond the value of 6.3, there was a decrease in the adsorption because
the surface site of the clay did not favor the adsorption of neutral TMP. By
performing kinetic experiments, the pseudo-second-order kinetic model provides
the best fit for TMP adsorption onto KSF and K10 montmorillonites. In the
optimum treatment conditions, the amount of drug adsorbed was 60 mg/g for 1
hour of contact time when its initial compound concentration was 290.3 mg/L; this
resulted in a removal for TMP of 20.7%.
A low-cost carbon black has been studied as an adsorbent for the removal
of TMP from aqueous solution (Dominguez-Vargas and Carrillo-Perez 2012).
After analysis of the variances between temperature, pH and ionic strength, these
researchers reported that an optimum removal was found at pH = 9.2, T = 47 °C,
and I = 0.48 M. Under these conditions, a maximum value of removal efficiency
equal to 156.2 mg of TMP per gram of adsorbent was achieved.
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B. Membrane Reactor
Membrane bioreactor (MBR) technology combines the biological
degradation process using activated sludge with a direct solid–liquid separation by
membrane filtration. The key components of the MBR include a fine screen, a
bioreactor tank (to achieve nitrification and de-nitrification), two parallelsubmerged membrane modules (made of hollow fiber membranes) and a medium
pressure ultra-violet (UV) disinfection unit.
In 2012, Schröder (Schröder, et al. 2012) evaluated a treatment of
wastewater in two MBRs. The wastewater contained three non-steroidal, antiinflammatory drugs (NSAIDs) and three antibiotics, including trimethoprim. The
results showed that NSAIDs (range from 86-100%) were removed with higher
efficiencies than the antibiotics (range from 55-86%) on both MBRs. At the same
year, another group of research (Trinh, et al. 2012) characterized the removal of 48
trace organic chemical contaminants through a MBR in Australia. Their results
indicted that the removals of most of the drugs were high (above 90%); however,
others removal efficiencies were only 24-68%. For example, the initial
concentration of trimethoprim was 100 ng/L in raw sewage, after 10 days sludge
retention time (SRT) of the bioreactor, its final removal efficiency was only 38%.
Thus, TMP has been identified as persistent compounds that are difficult to be
removed through MBRs.

	
  

32

C. Photolysis
Photolysis is a potential means to limit the release of pharmaceuticals drug
carried by wastewater effluents into the environment. Photo-degradation occurs
either by an engineered ultraviolet light photolysis system or in natural sunlight.
In 2011, Ryan et al. (Ryan, Tan and Arnold 2011) studied the direct and
indirect photolysis of TMP in wastewater treatment plant effluent exposed to
sunlight. In the wastewater effluent tests, photolysis could be divided into 18%
direct photolysis and 82% indirect photolysis, that latter including 62% reaction
with hydroxyl radicals and 20% reaction with triplet excited effluent organic
matter. These results indicated that allowing photolysis in wastewater stabilization
ponds or wastewater treatment wetlands may lead to enhanced pharmaceutical
removal prior to discharge into environment. However, some toxicity of oxidation
products were observed (Sirtori, et al. 2010).

D. Oxidation Reaction
Chemical oxidation processes have been widely applied to water treatment
and may serve as a tool to minimize the release of TMP into the aquatic
environment. The potential of several oxidants for the transformation of TMP was
listed, assessed and compared. The oxidants include ozone (O3), ferrate (VI),
potassium permanganate (KMnO4; Mn(VII)), chlorine (HOCl), chlorine dioxide
(ClO2), hydroxyl radicals (HO-), and UV-TiO2 photo-catalysis.
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Ozonation of TMP in municipal wastewater generally yields sufficient
structural modification of antibacterial molecules to eliminate their antibacterial
activities (Dodd, Kohler and Gunten 2009). The study has shown a 90% removal
with ozone. However, the removal may not necessarily obviate the antibacterial
properties completely since the 2,4-diaminopyrimidine substructure was present in
some of the degradants (Radjenovic, et al. 2009), therefore raising the concern of
production of carcinogenic bromate ion in the treated water.
Anquandah et al (Anquandah, et al. 2011) presented a work that described
for the first time that the oxidant, ferrate(VI) (Fe(VI)), degraded TMP completely
with cleavage of the original molecule, oxidation of amino groups of the
pyrimidine moiety, and finally the elimination the antibacterial activity of TMP.
Mn(VII) oxidizes a wide range of organic pollutants. Hu et al (Hu, Martin
and Strathmann 2010) examined the oxidation of TMP by potassium
permanganate (KMnO4; Mn(VII)). The reaction kinetics of trimethoprim were
described by second-order rate laws with apparent second-order rate constants
k2=1.6 ± 0.1 M-1s-1 at pH 7 and 25 °C condition. And the rates of trimethoprim
oxidation exhibited marked pH dependences. The Mn(VII) reactivity with the
antibiotics resulted in a removal rate range of 74-80%, which was lower than that
reported for ozone.
Ho et al (Ho, et al. 2011) used a photo-catalyst accompanied with the
oxidation process to remove residual TMP from water. The results indicated that
TiO2/UV photo-oxidation was effective in removing TMP, and the mineralization
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is about 80% within 180 min of irradiation. Furthermore, a lower flow rate and
higher detention time achieved higher percentage of TMP mineralization.

1.3.3 GEMFIBROZIL
Other non-antibiotic, active pharmaceutical for human usage also has an
emerging environmental issue because of possible impacts for environment.
Gemfibrozil (GEM) is a FDA-approved fibrate drug, commonly known as “lopid”
in the pharmacy. Gemfibrozil is used as a hypolipidemic drug to decrease very
low-density lipoprotein (VLDL) levels in the blood stream. Like a triglyceridelowering agent, GEM promotes the lipolysis of VLDL-triglycerides through
activation of lipoprotein lipase. GEM is an amphipathic carboxylic acid molecule,
its chemical formula and properties are presented in Figure 1.5 and Table 1.6,
respectively.
Gemfibrozil was designed first at the Parke Davis Research Laboratories at
Detroit in 1968 aimed to lower serum lipid. After years of research in clinical trial,
in 1976, GEM was successfully introduced in the market as a hypolipidemic drug
with its profound ability to reduce plasma triglyceride level (Betteridge, Higgins
and Galton 1976). It was then first marketed in the United States of America in the
year of 1982 (Wysowski, Kennedy and Gross 1990).
Gemfibrozil has some general advantages over other lipid lowering drugs.
First of all, it can be administered orally which is less painful. Secondly, it
generates relatively less amount of side effects compared to other lipid-lowering
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Figure 1.5 The structure of gemfibrozil

Properties

Molecular formula

5-(2,5-dimethylphenoxy)2,2-dimethyl-pentanoic acid
C15H22O3

CAS

25812-30-0

Molecular weight

250.33

Water Solubility

Insoluble (19 µg/mL)

Ethanol Solubility

Soluble (100 mg/mL)

Melting point

61 - 63 °C

Storage temperature

RT at 25 °C

pKa values

4.7

IUPAC Systematic Name

Table 1.6 Properties of gemfibrozil
(Gennaro 1995, Budavari 1995, American Hospital Formulary Service 1995)
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agents. Therefore, it drug has been widely used since the early 1980s to lower
serum triglycerides and raise high-density lipoprotein-cholesterol in patients.
However, its widespread use also suggests that GEM have the potential to
occur commonly in wastewater and ultimately the environment via excretion with
urine and feces as parent compounds, conjugated compounds, or metabolites (Xia,
et al. 2005). Several studies have suggested that GEM can’t be completely
removed by wastewater treatment process (Fang, et al. 2012) and has been
detected in wastewater treatment plant influents, effluents, and drinking water as
shown in Table 1.7. The GEM concentrations in wastewater may also vary
between worldwide countries due to different national pharmaceutical
consumption and wastewater production. For example, in North America, the
concentration of GEM in wastes effluent was approximately 0.75 µg/L while in
Europe, the concentration was about 1.5 µg/L (Sanderson, et al. 2003). In addition,
GEM has a longer degradation half-lives compared with other pharmaceuticals,
17.8-20.6 days for different textures of soil (Fang, et al. 2012).

Source

Concentrations of gemfibrozil
(µg/L)

Treated wastewater

0.08 - 19.4

Surface water

0.009 - 0.51

Drinking water

0.07

Table 1.7 The concentrations of GEM in various source of water (Skolness, et al. 2012)
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Even though the environmental risks associated with the presence of GEM
in water are unknown and little information exists about the effect of GEM in
aquatic organisms, gemfibrozil residue in wastewater has attracted much interests
due to its consumption, physical and chemical properties, toxicity, and water
persistence. GEM has been included in the current contaminant candidate list
published by US EPA (US EPA 2009). Considerable work has been carried out on
the degradation of gemfibrozil by a variety of wastewater techniques.
P. Falås et al (Falås, et al. 2012) studied the influent and effluent
pharmaceuticals concentrations compiled from the Swedish wastewater treatment
plants. Swedish WWTPs comprised a large spectrum of biological wastewater
treatment technologies, where organic micro-pollutants could be stripped to air,
absorbed to the biomass, and degraded by microorganisms. The final reduction
degrees were observed for GEM in activated sludge plants with extended nitrogen
is 32%.
Ying (Ying, Kookanab and Kolpin 2009) investigated eight selected
pharmaceutically compounds (including GEM) in effluents from fifteen sewage
treatment plants (STPs) across South Australia. The removals of these compounds
in four STPs were carried out by different technologies (Plant A: conventional
activated sludge; plant B: two oxidation ditches; plant C: three bioreactors; and
plant D: ten lagoons in series). Plant A was a large conventional, municipal,
activated STPs and the other three plants were small, rural STPs. The table 1.8
shows more details of these technologies and includes the removal efficiencies of
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GEM. Gemfibrozil exhibited variable removal efficiencies within the four STPs.
Biodegradation (Plant B) had a significant concentration decreases between
influent and effluent and was found to be the main mechanism for removing
concentrations from the liquid waste stream for GEM within the four STPs, while
Plant D had the least efficient.

Plant

Treatment process

A

conventional
activated
sludge

B

two oxidation
ditches

C

three
bioreactors

D

ten lagoons in
series

primary sedimentation
secondary activated sludge
process
tertiary stage of six
lagoons.
biological process
with two oxidation ditches
followed by chlorination
an activated sludge process
with three bioreactors
followed by UV
disinfection and
chlorination
10 lagoons operated in
series:
2 parallel anaerobic
lagoons followe by 8
aerobic lagoons with only
lagoon 3 aerated

Discharged

Removal
efficiencies

1) sea
2) irrigation
reused

78

small creeks

90

small creeks

72

small creeks

15

Table 1.8 The GEM removal efficiencies (%) in the four sewage treatment plants

Oxidation techniques have also been proven as an effective method to
remove potential pollutants in wastewater that cannot be degraded biologically
with the benefits of disinfection effect. As the same as the oxidants that used for
trimethoprim, various oxidants can be employed in the wastewater treatment, such
as Ozone (O3), chlorine, chlorine dioxide (ClO2) and peracetic acid (PAA).
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To explore the efficiency of those oxidants that have not been extensively
studied, Hey et al (Hey, et al. 2012) studied the effectiveness of ClO2 and PAA on
the removal of GEM in biologically treated wastewater. Their result showed that
GEM was removed only when treated with higher dose of ClO2 (20 mg/L) in the
low COD wastewater, whereas higher removal was observed in medium and high
COD wastewater at much lower ClO2 dose (1.25 mg/L). In the case of PAA, GEM
was less reactive at lower PAA dose in all COD effluents, but it was gradually
removed for 25% with increasing PAA dose to 15 mg/L. The higher removal
efficiency (75%) occurred at 15 mg/L PAA dose. However for the medium and
high COD wastewater, the best removal efficiency was only 20% achieved by the
highest oxidant dose. Hence, ClO2 is more effective than PAA at removing GEM
in wastewater.

1.3.4 SUMMARY
Pharmaceutical residues are widespread in the environment at trace
quantities. Most of them come from excreta of human and animals, waste effluents
of manufacturing processes, and disposals of unused or expired drug products.
Researchers have detected them in drinking. These residues indicate that the
applied water treatment technologies are not efficient enough to eliminate
pharmaceutical from natural waters. Therefore, it’s difficult to predict human
health risks from exposure at the drinking water that includes innumerable
pharmaceutical drugs and their transformation products.
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This section mainly showed the occurrences, fates and removal
technologies of two substances including an antibiotic (trimethoprim) and a fibrate
drug (gemfibrozil). Both of these drugs have been found in several countries’
wastewater effluent. Even though large amounts of technologies have been
researched and developed to help remove these pharmaceuticals, these drugs still
persist in treated wastewaters.

1.4 RESEARCH OBJECTIVES
The research objectives of this study were to 1) evaluate wet-air oxidation
as a treatment technique for two persistent pharmaceutical compounds in
wastewater and 2) evaluate the importance of organic matter content on the
removal capability of wet-air oxidation.
With the rapid increase in population and the increased demand to meet
human requirements, new technological advancements are needed to improve
water quality, even through various conventional and advanced technologies are
used currently. From an economic point of view, it is also interesting to develop
some knowledge and methods on the energy balance of the process, along with
energy recovery and savings. This concern is very important when high quantities
of wastewater are to be treated.
Wet-air oxidation is considered an effective treatment of hazardous and
toxic wastes, without emissions of any toxic effluent and gas. To determine the
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optimal removal efficiency of certain pharmaceuticals, this study tried to explore
the relationships between different operation parameters of the oxidation process.
The operation parameters discussed in the thesis including the reaction time, target
concentration, sample volume, oxygen supply (as a function of applied air
pressure) and external organic matters. Trimethoprim and gemfibrozil were chosen
as the two pharmaceutical contaminants to evaluate in this work because of their
frequent appearance in surface and drinking water, implying these drugs resist
removal and/or treatment in typical wastewater treatment operations and thus are
detected in aquatic systems.
Trimethoprim as an important antibacterial agent has been used in human
and veterinary medicine worldwide for long years. However, the widespread use
of the antibiotics, coupled with their subsequent release into the environment merit
a great concern. Gemfibrozil, as a hypolipidemic drug, has recently been detected
in multiple water sources. Even though little information exists about the effect of
GEM in aquatic organisms, gemfibrozil residues in wastewater are of concern due
to its persistence in water after treatment.
Analytical methods needed to be developed to the detect and quantify these
pharmaceutical compounds during the experiments needed to meet the research
objections. These methods required quantification of the drugs using calibration
curves, and using these values to determine the removal efficiency of the drugs by
comparing drug concentrations before and after sample treatment by WAO.
Reversed-phase liquid chromatographic techniques were a first step in the
	
  

42

development of analytical techniques since the major focus of this research is in
aqueous systems. The appropriate selections of RPLC columns, mobile phase
solutions, flow rate, injection volume and detection wavelength where significant
and important steps needed to develop a sensitive RPLC detection method.
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CHAPTER 2 TRIMETHOPRIM
2.1 INTRODUCTION
Trimethoprim is among the most commonly human-used antibacterial
compounds that are prescribed worldwide to treat various bacterial infections for a
number of years (Ryan, Tan and Arnold 2011). As described in Chapter 1,
detectable concentrations of the drug are detected in the treated wastes from
wastewater treatment plants. The discharge of effluent to surface waters leads to
the potential contamination of environmental systems with the residual
pharmaceutical. Concerns about TMP include the potential for the development of
bacterial resistance to due to increased use, the alteration of microbial
communities and risks to the health of humans (Kublin, et al. 2010) (Lindsey,
Meyer and Thurman 2001)(Golet, Alder and Giger 2002).
This chapter discusses the application of wet-air oxidation in the removal
of TMP from water solutions. The wastes resulting from WWTPs are very
complex. To avoid the effects of environmental factors and minimize the hazards
associated with handling sewage, a synthetic wastewater is used in the studies
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reported here that contains only TMP and a surrogate organic material to simulate
sewage instead of using the real wastes from natural microbial community that
contains TMP. The aim of this chapter is to explore the relationships between three
experimental parameters of the wet-air oxidation process and optimize reaction
conditions to obtain the best removal efficiency.

2.2 MATERIAL / EXPERIMENT DESIGN
2.2.1 CHEMICALS
Trimethoprim (purity = 99.5%) were purchased from Sigma (St. Louis,
MO). Acetonitrile (ACN) of reversed-phase liquid chromatography (RPLC) grade
was supplied by Sigma, and analytical grade ammonium acetate by Panreac
(Barcelona, Spain). RPLC grade water was obtained from a Thermo Scientific
water purification system. A 1,000 mg/L stock solution of TMP was prepared by
dissolving 0.05 g of TMP in ACN and diluting to 50 mL with ACN in a
volumetric flask. The stock solution was stored in stoppered flasks until needed at
4 °C in the dark.

2.2.2 WET-AIR OXIDATION
A. Vertical Tube Reactor Introduction
A detailed schematic diagram of the laboratory vertical tube reactor (VTR)
is provided in Figure 2.1. Briefly, the laboratory VTR contains a sample charge
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Figure 2.1 Schematic of the detailed rotating vertical tube reactor
Inset: Liquid sample introduction apparatus
(Connors 2009)
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Figure 2.2 The control board of VTR with monitors and switches
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vessel that is constructed of stainless steel and is connected to a low-pressure air
source. Samples are “charged” to the reactor chamber, that is approximately 1L,
using the low-pressure air source. The typical liquid sample volumes were 500mL
in order to provide adequate mixing space with the vapor phase (Connors 2009).
The reactor tube was rotated via an air actuator (Pneuturn®, Bimba,
Monee, Il), which is controlled with a regulated nitrogen cylinder. The outside of
the reactor vessel is wrapped with heat tape and conductive heating wire that are
used to control the temperature of the reactor. Control of the heat tape is
accomplished using a rheostat. Three K-type thermocouples are used to monitor
the reaction temperature at each end and the middle of the tube, and the reactor
temperature is reported on the front of the VTR console as shown in the Figure
2.2. The pressure is monitored via a pressure sensor during all phases of an
experiment (See Figure 2.2). In order to facilitate rapid cooling of the reaction
chamber after completion of the heating cycle and to simulate the transit of
wastewater through a full-scale VTR treatment system, house air is connected to a
cooling tube running alongside the reaction tube that results in an increase of heat
removal from the reaction vessel. An evacuation valve is placed at the end of the
reactor tube for the release of treated sample. As shown in the Figure 2.2, in
addition to the temperature and pressure monitors, there is a power switch, a
rotation switch, a voltage switch (to control the temperature increase rate) and an
air pressure control control switch (to determine the initial pressure of breathing
air charged to the reactor).
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B. Sample preparation
To achieve the necessary concentrations (1, 5, 10, 20 ppm, respectively) for
calibration standards and samples, the TMP stock solution was diluted with pure
water to the final sample volume (500 ml). An additional 2.25g sucrose (4,500
ppm) was added to and dissolved in the sample to provide the necessary organic
matter to simulate organic matter that would be present in wastewater.

C. WAO operation procedures
The basic WAO operation procedures for adding a sample to the reactor and
completing one test run are described below:
1. Clean the wet-air oxidation reactor using water. [Note, if needed, treat
with a 1% (v/v) solution of nitric acid to remove scale buildup. After acid
treatment, flush the reactor with clean water until pH is neutral.]
2. Charge the sample liquid (500 ml) into the reactor by pressuring the
flask with house air pressure (23 psi).
3. Open the valve from the breathing air tank to add breathing air to inside
the reactor chamber.
4. Set the pressure at 300 psi (or other pressure desired for experiment) and
close the breathing air pressure control to isolate the system.
5. Switch the rotation control to start rotating the vertical tube reactor.
6. Start heating (this point was defined as “zero time” in all experiments)
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so that a reactor temperature of 260 °C is arrived at in approximately 30
minutes.
7. Reduce the applied current to the heating tape and allow the reactor to
cool for approximately 30 minutes by itself.
8. After the 30-minute wait, provide an additional cooling to the reactor by
pumping house air through the cooling tube.
9. Discharge the reacted liquid to a sample container and store until analyze
by RPLC.

2.2.3 RPLC METHODS
To quantify the removal efficiency of TMP, a RPLC method with UV
detection was used to measure the concentration of the analyte and other organic
compounds before and after the oxidation process. An Agilent 1100 Series binary
RPLC system with a multiple wavelength detector and auto-sampler was used for
all separations (Agilent, Santa Clara, CA). Samples were injected without further
treatment. At a flow rate of 0.6 ml/min, 5 µL sample volumes were separated
isocratically with 80:20 (v/v) mobile phase A: B (mobile phase A: 1mM ammonia
acetate, 0.01% (v/v) glacial acetic acid and 10% (v/v) ACN water solution; mobile
phase B: 100% ACN) on a X Bridge C-18 column (4.6 mm × 75 mm, 2.5 µm)
(made in Ireland). UV detection was performed at a wavelength of 230 nm (Renew
and Huang 2004). All quantifications were based upon peak areas integrated with
the Agilent ChemStation® software and their corresponding concentrations
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calculated from the calibration curve constructed with the standards.

2.3 RESULT AND DISCUSSION
2.3.1 CHROMATOGRAPHY
Trimethoprim appears as a sharp peak at the retention time of 2.4 min in
the chromatographic condition described above. Figure 2.3 shows the result of a
representative injection of a10 ppm standard trimethoprim sample with the sample
area of 419.56 mAU*s.

2.3.2 STANDARD CURVE
At the same chromatographic conditions described above, all of the four
standard samples were tested, and the resulting chromatograms presented in Figure
2.4 were obtained. From this figure, the peak shapes of the samples gradually
become asymmetric with increasing concentrations. The main factors that
influence peak symmetry depend upon retention, solvent effects, incompatibility of
the solute with the mobile phase, or a development of an excessive void at the inlet
of the column. In this work, the latter explanation could be eliminated since the
column used for these studies was relatively new. In RPLC, adsorption phenomena
due to the presence of residual silanol groups in the stationary phase may also lead
to tailing (poor peak symmetry) (World Health Organization 2006). However,
since this study was completed with only one compound, TMP, the asymmetry of
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Figure 2.3 Chromatogram of 10 ppm standard sample of trimethoprim
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Figure 2.4 Chromatogram of the five standard trimethoprim samples:
1 ppm (a); 5 ppm (b); 10 ppm (c); 20 ppm (d).
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3.5

the chromatographic peak was not considered detrimental to the quantification of
TMP.
According to the increased peak areas of these four standard samples, a
calibration curve within the tested ranges of 1-20 ppm was found for trimethoprim
(Figure 2.5). The calibration curve was linear within this range, and the correlation
coefficient was 0.998, which indicates the regression line fits the data very well as
demonstrated with the equation of the line reported on Figure 2.5. Hence,
according to the equation (y = 45.76x-6.91) and peak area results, it is possible to
calculate the exact concentration of the sample. Because no physical quantity can
be measured with perfect certainty and there are always experiment errors in any
measurement, a minimum of three replicates, unless otherwise reported, were
performed with each sample to provide an estimate of uncertainty.

2.3.3 OXIDATION REACTION
As reported in Chapter 1, wet-air oxidation systems remove organic
contaminants and yield carbon dioxide, water and biodegradable short-chain
organic acids. In order to see whether the WAO process could remove TMP
successfully, TMP sample solutions were analyzed before and after WAO
reaction; representative results are shown in Figure 2.6 from the reaction of a 10
ppm solution of TMP. The sample after reaction (AR) has a smaller peak at the
retention time of TMP (2.6 min) compared with the sample before reaction (BR),
which indicates most of the TMP has been oxidized. Two additional repeated trials
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Figure 2.5 Regression curve for trimethoprim – standard sample
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Figure 2.6 Chromatogram results from the analysis of 10 ppm standard samples
before (a) and after (b) the wet-air oxidation
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were conducted and the peak areas from all chromatogram results where used to
calculate the final concentrations from the calibration curve. The results indicated
that, in the case of the 10 ppm BR concentration, the AR concentrations were 1.42
ppm, 1.36 ppm and 1.41 ppm, respectively, resulting in a mean removal efficiency
of 85.4 ± 0.1 %.
Other peaks, besides TMP, associate with the elution of the products of the
oxidation reaction were also detected using the RPLC methods. Unfortunately,
these degradation products have not been determined at this time. Further research
using mass spectrometry and ion chromatography is planned in the near future to
determine the identity of these compounds.

2.3.4 SOLVENT ADJUSTMENT
As shown in Figure 2.6, two chromatographic peaks closely appear in the
time range of 2.4 – 3.0 min. One of the peaks represents the TMP and the other
peak belongs presumably to a degradation product. To increase the
chromatographic resolution between the two peaks, the 10 ppm reacted sample
was injected onto the column with three different mobile phase ratio to study the
effect of solvent to the final resolution and to try to separate these two peaks.
Figure 2.7 presents the chromatographic results of injected sample using the three
different solvent ratios. Since mobile phased A is 1mM ammonia acetate, 0.01%
glacial acetic acid and 10% ACN solution and mobile phase B is pure organic
ACN solvent, increasing the percentage of A means that mobile phase contains
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Figure 2.7 Chromatograms of the separation of BF and AF using different mobile phase
ratio: (a) A:B=85:15; (b) A:B=90:10; (c) A:B=95:5
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more water and thus become a more polar, which increases retention times. This is
because more polar solvent makes the affinity of the hydrophobic analyte to the
hydrophobic stationary phase stronger relative to the now more hydrophilic mobile
phase. Hence, these two peaks shift to the right and both have longer retention
times. It is important to note that the TMP peak shifts from 2.44, to 2.96 and
finally to 3.38 min, while the peak associated with a degradation product shifts
from 2.67, to 3.30 to 5.40 min. Because of the shift differences, the compounds
can be effectively separated. When using the mobile phase composition of A and
B (90:10, v/v), the two close peaks can be baseline separated. For the
chromatographic run using the mobile phase composition A:B at 95:5 (v/v), the
sample analysis takes too much time for the second peak to elute. Thus, despite
the complete separation of both compounds, the resulting long analysis time
corresponds to a time and solvent waste for subsequent sample analyses. Thus, the
mobile phase composition of 90:10 (A:B) was determined to be the most
appropriate for analysis of TMP degradation products for this study.

2.3.5 REMOVAL EFFICIENCY
Several factors are capable of influencing the effectiveness of the WAO
reaction. The optimal combination of all these factors allows one to obtain the best
degradation yield. In Section 2.3.3, the removal efficiency of 10 ppm standard
TMP sample was 85.4 ± 0.1 % as shown in Figure 2.6. To determine this best
combination of other operational parameters and thus achieve a higher removal
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percentage of this contaminant, a series of experiments were conducted to
investigate the effect of individual factors for oxidation of the antibiotic, including
the time the reaction is held at the high temperature, the initial TMP concentration
and the volume of sample charged to the laboratory VTR.

A. Residence Time
Temperature is always one of the most important factors that impact the
degree of oxidation in WAO processes. To investigate the effectiveness of the test
conditions for the TMP degradation studies, three control trials were conducted.
Since the laboratory VTR simulates the flow of wastewater through a vertical tube,
instead of increasing the reaction temperature, the temperature was held at the
highest point investigated to study the influence of the residence time to the final
removal result. This effectively simulates a slower flow of wastewater through the
full-scale VTR.. The only difference between these trials was to increase the
residence time at 260 °C an addition 15 and 30 minutes. The entire timetemperature profile for the laboratory VTR is showed in Figure 2.8, which again,
represents the simulation time of the waste spending in a full-scale VTR.
Three trials for each sample condition were performed. The effect of
increased reaction time on TMP oxidation by WAO is shown in Figure 2.9;
summaries are also presented in Table 2.1 along with all other experimental results
from the optimization study.
The results show that the reaction time has a markedly progressive effect,
	
  

60

Figure 2.8 Time profile of the wet-air oxidation process
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Figure 2.9 Degradation of TMP: Variation of the residence time at 260 °C
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most notably when the reaction time was increased from 0 min to 15 min. This
additional 15 minutes resulted in the removal efficiency increasing from 85.4 ± 0.1
% to 90.2 ± 0.4 %, resulting in almost 5 % removal improvement. However, this
effect was not as pronounce when the time was increased into 30 min, because the
additional 15-minute time increase only achieves a 2 % additional improvement.
This means that there is a significant yield variation between the reaction time of 0
-15 min, and in experiments conducted at 30 min, there is smaller difference for
oxidation. In other words, the second 15 min difference does not have the same
marked effect as the first 15 min .
The wet-air oxidation is known to follow a free radical mechanism (Li,
Chen and Gloyna 1991). The breaking of the chemical bonds breaking is under the
direct influence of the temperature and the reaction time. Longer reaction time will
provide enough energy for the bond breaking and fulfill a more complete oxidation
reaction. The more the reaction time is retained, the more the necessary energy for
this breakage is sufficient.
While the time differences between the increase from 15 and 30 minutes
are not easily explained, the impact of increased reaction time, in general, can be
explained by what is known about mechanisms associated with the WAO process.
The wet-air oxidation is known to follow a free radical mechanism (Li, Chen and
Gloyna 1991). The breaking of the chemical bonds breaking is under the direct
influence of the temperature and the reaction time. Thus, a longer reaction time
will provide more net energy for the bond breaking and will result in a more
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complete oxidation reaction. Therefore, the longer the reaction was held at the
higher temperature, the more the necessary energy required for radical formation
and bond breakage was supplied to the reaction mixture.

B. Initial target Concentration
The efficiency of pollutants removal by WAO has been reported by some
researchers to be impacted by the characteristics of wastewater; in particular, some
researchers have reported the initial concentration of the pollutants impact removal
efficiency (Lei, et al. 2007). Others, however, have reported that the initial
concentration of wastewater had little influence on the removal efficiency while
others argued that higher initial concentration favored the wastewater treatment
(Fu, Chen and Liang 2005).
In this study, the experiments completed at identical reaction time, but with
various initial TMP concentrations were found to have a measureable effect on the
removals of TMP by WAO. The samples with different initial concentrations (0.5,
1, 5 and 10 ppm) were oxidized under identical reaction conditions (the same
reaction time and temperature). After the reactions and analysis of each sample,
the mean percentage of TMP oxidation as a function of the initial concentration of
TMP was plotted and evaluated. These results are summarized in Figure 2.10. All
samples were analyzed in triplicate with the exception of the lowest sample (500
ppb), which was only analyzed twice.
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Figure 2.10 Result of trimethoprim oxidation at initial concentrations of
#1: 0.5 ppm, #2: 1 ppm, #3: 5 ppm and #4: 10 ppm
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As shown in Figure 2.10, it was observed that with the decrease in the
concentration of the TMP solution, the measured degradation of TMP decreases
slightly from 91.9 to 86.6 % between 10 ppm and 0.5 ppm. Since the differences
between these samples are little (within the range of 5.5 %), the starting TMP
concentration has almost none effect for the removal efficiency. In addition, for
the trial of sample #1 (0.5 ppm) the concentration of the treated sample was below
the detection limit of the UV detector even after the sample injection volume was
increased from 5 to 40 µL. Thus, it is difficult to predict precisely what the
removal efficiency of TMP solutions at lower concentrations (ppb) will be.
However, for the purposes of the evaluation of WAO as feasible wastewater
treatment option, the measured decrease indicated that the initial concentration of
TMP did not have a pronounced impact of the degradation efficiency for the ppm
concentration range.

C. Sample Volume
The effect of sample volume of the aqueous solution on TMP removal is
shown in Table 2.1. In this experiment, solutions, consisting of 10 ppm TMP, were
treated with a 30-min hold time at 260 °C . Solutions were prepared in volumes of
500 and 300 ml solution. As shown in Table 2.1, the 300 ml solution results in a
TMP mean removal of approximately 88.7 %, which is lower than the 91.9 % of
500 ml experiment. Even though this proved that 500 ml volume was optimal for
the reactor configuration, the differences vary only 3% after increasing the sample
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Factor

Variables

0min

Residence
Time

15min

30min

0.5ppm

1ppm
Initial
Concentration
5ppm

10ppm

300
Sample
Volume
500

BF
(ppm)

AF
(ppm)

%
Oxidation

9.78

1.42

85.5

9.33

1.36

85.4

9.56

1.41

85.3

9.70

0.95

90.2

8.90

0.84

90.6

9.50

0.97

89.8

9.83

0.80

91.9

9.05

0.76

91.6

9.80

0.76

92.2

0.31

0.05

83.9

0.45

0.06

86.6

0.95

0.10

89.5

0.95

0.11

88.4

0.99

0.12

87.9

4.60

0.5

89.1

4.70

0.47

90.0

4.90

0.58

88.2

9.83

0.80

91.9

9.05

0.76

91.6

9.80

0.76

92.2

9.10

1.06

88.4

9.43

1.01

89.3

9.87

1.13

88.6

9.83

0.80

91.9

9.05

0.76

91.6

9.80

0.76

92.2

STDEV

Mean %
oxidation

0.1

85.4

0.4

90.2

0.3

91.9

1.9

86.6*

0.8

88.6

0.9

89.1

0.3

91.9

0.5

88.7

0.3

91.9

Table 2.1 Influence of various operation factors on TMP oxidation by WAO
*For the trial of 0.5 ppm, the concentration is too low to be detected by UV and there are
experimental errors existing. Thus, it has a higher deviation than others. I assumed that the
second trial of 0.5 ppm represented the result because its initial concentration was closes
to 0.5 ppm.
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volume. Therefore, sample volume has a relatively small effect on TMP removal
when compared to the other parameters that were varied.

2.4 CONCLUSIONS
In this chapter, the wet-air oxidation process was tested as an alternative
technology for the removal of TMP. The WAO process is indeed a promising
technology for degradation of this persistent pharmaceutical because it is capable
of reducing the concentration of TMP in water solutions with the removal
efficiency ranging from 85.4 % to 91.9 %, which has equal or higher removal
efficiency when compared with other previously reported removal methods that
were described in section 1.3.2.
In addition, a RPLC method was optimized for the determination of
trimethoprim in water solutions. Using this developed method, the peak areas
obtained from RPLC chromatographs provide a linear relationship between the
concentration of TMP and chromatograph peak area.
In the last section of this chapter, experiments under common WAO
conditions (260 °C, 300 psi of breathing air pressure) were carried out to study the
effect of the operation parameters to TMP removal. Results showed that reaction
time was the most important factor for wet-air oxidation of the antibiotic. A longer
reaction time help remove TMP from 85.4 % (without hold at 260 °C) to 90.2 %
(15 min hold at 260 °C). For the initial target concentration, only a slight decrease
in degradation efficiency was observed when the initial concentration of TMP was
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reduced. Finally, for the test using the laboratory VTR system, the results from the
sample volume study showed that no significant gains in oxidation efficiency for
TMP could be made by altering the volume of the sample to be treated.
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CHAPTER 3 GEMFIBROZIL
3.1 INTRODUCTION
Gemfibrozil is an emerging contaminant that has received noticeable
attention over the past few years. This is because it has been detected in trace
quantities in both groundwater and surface waters that are used for drinking water
supplies. Some concerns have been raised over the potential risk to human health
from exposure to this pharmaceutical residue via drinking water, although it
should be noted that no health concerns have been raised yet associate with the
detection of the gemfibrozil in these waters. However, continual development of
advanced instrumentation and the improved analytical methods have made
possible the detection of the pharmaceuticals at low levels (ppb to ppt) in different
environmental matrices.
In this chapter, the application of wet-air oxidation to the removal of
gemfibrozil (GEM) in water solutions is studied. As the Chapter 2, a surrogate
wastewater is used instead of actual wastewater so that only one type of
contaminant (GEM) is being treated, thus avoiding any unknown effects of other
	
  

70

environmental factors. The aim of this work was to explore and optimize for the
best removal efficiency of GEM in wastewater. In comparison to Chapter 2, this
chapter mainly discussed the effect of additional surfactant and organic matter on
the final removal efficiency of WAO by using the best operation parameters of the
oxidation process found in the previous chapter. Furthermore, the impact of drug
loss in the transfer piping of the laboratory VTR (and thus not effectively treated)
on overall WAO efficiency was study by quantifying the quantity of drug residue
that remained in the reactor tubing.

3.2 MATERIAL / EXPERIMENT DESIGN
3.2.1 CHEMICALS
Gemfibrozil (purity = 99.5%) were purchased from Sigma (St. Louis, MO).
Acetonitrile (ACN) of RPLC grade was supplied by Sigma, and phosphoric acid
(85%) was purchased from Sigma (St. Louis, MO). RPLC grade water was
obtained from a Thermo Scientific water purification system. A 10,000 mg/L stock
solution of GEM was prepared by dissolving 0.5 g of TMP in the methanol and
diluting to 50 mL. The solution was stored in stoppered flasks in the dark until
needed. A 10,000 mg/L stock solution of Triton X-100 (TX-100) was made by
dissolving 4.76 ml of Triton in 500 ml water and was stored in flasks at dark until
needed.
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3.2.2 WET-AIR OXIDATION
To achieve the required concentrations (5, 10, 20, 25, 40, 50 ppm,
respectively) of standards and samples, the GEM stock solution was diluted with
water. To study the effect of surfactant to the water solubility and removal
efficiency of GEM, an additional volume of TX-100 stock solution (50, 100 ml)
were added to the 500 ml sample to increase the concentration of surfactant (1,000,
2,000 ppm, respectively) of the aqueous system. To study the impact of other
forms of organic matter on the WAO process, varying amounts of formic acid and
sucrose were added in the experiments in an attempt to achieve higher oxidation
efficiencies.
After mixing all of additional compounds, the volume of all final
experiments was 500 ml. Then, the samples were ready for treatment using the
WAO . All WAO operation procedures were the same as the TMP, except with the
initial pressure of breathing air was 350 psi and fixed reaction time (10 min) at 260
°C.

3.2.3 RPLC METHODS
The concentration of GEM was determined by RPLC-UV detector (Agilent
Technologies, series 1100) equipped with a X Bridge C-18 column (4.6 mm × 75
mm, 2.5 µm) (made in Ireland). The detection wavelength was 230 nm, and all
analyses were conducted at room temperature. Separations were conducted using a
mobile phases of (A) pH 2.5 phosphoric acid solution and (B) acetonitrile. With
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the constant ratio 40:60 (v/v) of mobile phase A:B, GEM was eluted at 3.86 min
(METHOD 1) (Kublin, et al. 2010). When an additional TX-100s were added in
the system and in order to separate the TX-100 and GEM whose retention times
were both around 3.5-5 min, a gradient chromatographic elution was needed. It
was obtained by initially running 60% A, decrease to 50% from 4 to 5 min then
followed by a return of mobile phase A back to 60% in 1 min from 20 to 21 min.
The last 4 min of the gradient was held so that the column would re-equilibrate
prior to the next analysis. Thus, the overall run was completed in 25 min
(METHOD 2). The timetable for the mobile-phase gradient program is shown in
Figure 3.1. The overall the flow rate was set at 1 mL/min and all injection volumes
were 20 µL.
To quantify the formic acid production during WAO experiments with
GEM, the Phenomenex Synergi 4u Hydro-RP 80R column (4.6 mm × 250 mm, 4
µm) was used. The concentration of the acidic analytes was measured before and
after the oxidation process (METHOD 3). The detection wavelength was 230 nm
with the mobile phase of pH 2.5 phosphoric acid solution. The flow was set at 0.7
mL/min, injection volume was 20 µL, and the run was completed in 8 min. All
quantifications were based upon peak areas integrated with the Agilent
ChemStation® software and their correspond concentrations on the standard
calibration curve.
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Figure 3.1 The timetable of solvent for the RPLC METHOD 2
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3.3 RESULT AND DISCUSSION
3.3.1 CHROMATOGRAPHY
In the chromatographic analyis, a 40 ppm sample of gemfibrozil appears as
a sharp peak at the retention time of 3.86 min with the width of 0.09 min, the peak
height of 193.61 mAU and a peak area of 1111.82 mAU*s in the chromatographic
condition described above (METHOD 1). Figure 3.2 shows a representative RPLC
result of the 40 ppm standard gemfibrozil sample.

3.3.2 STANDARD CURVE
At the same chromatographic conditions described above (METHOD 1), all
of six standard samples were tested; increased peak areas of correlated with
increased sample injections, and the relationship was determined to be linear
within the tested ranges of 5-50 ppm for gemfibrozil. The calibration curve is
presented in Figure 3.3. The calibration curve was linear within this range and the
correlation coefficient was 0.999, which indicates the regression line fits the data
very well in accordance with the straight line in Figure 3.3. Hence, according to
the equation (y = 27.66x+4.50) and peak area results, it is possible to calculate the
concentration of the samples, both before and after treatment by WAO.
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Figure 3.2 Chromatogram of 40 ppm standard sample of gemfibrozil
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Figure 3.3 Regression curve for GEM – standard sample
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3.3.3 OXIDATION REACTION
As with TMP, wet-air oxidation system removes organic contaminants and
yields carbon dioxide, water and biodegradable short-chain organic acids. In order
to see whether this process could remove GEM successfully, samples before and
after WAO reaction were compared, and the results were shown in Figure 3.4. As
is Chapter 2, three trials were performed for each sample and the AR sample had
smaller peak than the BR sample. This indicated most of the GEM had been
oxidized. According to the calibration curve, the mean concentration of ARs was
11.27 ppm. Hence, the mean removal efficiency was calculated to be 71.6 ± 3.6%.
To study the some of the products of this oxidation, a Hydro-RP 80R
column was used to determine which acids were produced (METHOD 3). Figure
3.5 shows the results of BR and AR by using the Hydro-RP 80R column. The AR
had an apparent peak at 4.8 min, which didn’t exist in the BR result. This peak
belongs to the formic acid according to the formic acid standard sample, which
corresponds with the previous researches and findings that formic acid was one of
the major products of wet-air oxidation.

3.3.4 REMOVAL EFFICIENCY
Section 3.3.3 reported the removal efficiency of 40 ppm standard GEM
sample was 71.6 ± 3.6 %. In this section, to achieve a higher removal percentage
of GEM, the effect of additional organic materials including a non-ionic surfactant,
formic acid and sucrose on the final degradation and conversion into subsequent
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Figure 3.4 Chromatogram results from the analysis of 40 ppm samples before (a) and after
(b) the wet-air oxidation
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Figure 3.5 Chromatogram results from the analysis of acidic production of 40 ppm
samples before (a) and after (b) the wet-air oxidation
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intermediates such as organic acids, was investigated. The optimum WAO
conditions for the laboratory VTR that was determined from Chapter 2 for TMP
were used for these experiments.

A. Surfactant effect
Gemfibrozil is a hydrophobic, lipid-lowering drug with poor water
solubility, around 0.01 mg/mL (Kasim, et al. 2004), which might limit the ability
of the compound to be transported into the reactor for oxidation effectively. Due to
the hydrophobicity of the drug, the possibility of the drug sticking to the surfaces
of the transfer tubing of the laboratory reactor was a concern for this portion of the
research. Thus, this is the major reason why introducing a surfactant into the
GEM system was studied. One of the most important properties of surfactants is
that is they form micelles in solutions. This makes surfactants have particular
significance in pharmacy because of their ability to increase the solubility of
sparingly soluble substances in water (Mall, Buckton and Rawlins 1996). When
surfactant molecules are dissolved in water at concentrations above the critical
micelle concentration (cmc), they form aggregates called micelles (Rangel-Yagui,
Pessoa-Jr and Tavares 2005). Micelles are commonly used as drug delivery
devices to solubilize hydrophobic drug molecules.
In this thesis, the nonionic surfactant, Triton X-100 (Figure 3.6), was
selected and dissolved in water at concentration of 1,000 and 2,000 ppm, which is
above the cmc (0.22-0.24 mM, 137.5-150 ppm) for Triton X-100. Based on the
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presence of Triton X-100 micelles, GEM could have an increased solubility in the
aqueous system. This part aimed to study the effect of triton micelle on the GEM
removal efficiency.

n=9-10
Figure 3.6 Chemical structure of Triton X-100

Due to the presence of the micelles, a new RPLC method needed to be
developed. Thus, in order to have a better selectivity, METHOD 2 was developed
to analyze the mixture sample of 40 ppm GEM and 1,000 ppm TX-100. The
results are summarized in Figure 3.8(a). Gemfibrozil shifted and displayed a peak
at 12.48 min, and TX-100 had multiple peaks ranging from 15 to 18 min. Both of
the two components eluted at different retention times. A clear separation of them
was achieved at 230 mm wavelength and no interference between the eluting
peaks was observed. Therefore, a combined solution of GEM and TX-100 was
directly used for the quantitation studies of these two individual components.
At the METHOD 2 chromatographic conditions, all of the six standard
samples were tested within the ranges of 50 – 1,000 ppm for TX-100. The
calibration curve is presented in Figure 3.7.
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Figure 3.7 Regression curve for TX-100 – standard sample
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To study the GEM removal efficiency, the peak areas for both GEM and
TX-100 were determined for each sample. Figure 3.8 provides a representative
example of samples before and after the WAO reaction. Using the peak area
intensity and the calibration curve, the GEM and TX-100 concentration of BR and
AR is 40.03 ppm and 1005.63 ppm, 8.75 ppm and 675.86 ppm, respectively. Thus,
the final removal of GEM is 78.2 % and of TX-100 is 32.8 %.
Table 3.1 shows the variation of initial GEM, TX-100 and breathing air
pressure in the WAO oxidation when the drug and surfactant are varied. Higher
oxidation efficiency could be achieved if the surfactant was introduced into the
system (#1 and #3, 71.60 to 79.9 %), but too high of a surfactant concentration in
the solution did not help achieve the goal of increased oxidation efficiency (#1 and
#6, 71.6 to 71.3). This is because the WAO process is not necessarily selective for
each type of organic matter; rather the process oxidizes all of the various forms of
organic material in the solution, which includes both the GEM and TX-100. From
the results of trial #1 and #2, the removals of individual GEM and TX-100 are 71.6
% and 90.1 %, respectively Within certain amounts of TX-100, the surfactant
could help increase the solubility of GEM, thus have higher removal efficiency.
However, the presence of 2,000 ppm TX-100s is so concentrated that parts of the
energy (and oxygen from the breathing air that was used to pressurize the system)
would be used for removal the TX-100, which is not what was originally expected.
To test the previous conclusion in Chapter 2, specifically that higher
removal efficiencies were obtained the longer the reaction was held time at 260°C,
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Figure 3.8 Chromatogram results from the analysis of the 40 ppm samples with 1,000ppm
TX-100 before (a) and after (b) the wet-air oxidation
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trials #4 and #5 were conducted. Comparing the result of trial #3 to trial #4, the
mean GEM oxidation results did increase from 79.9 % to 90.2 %, which proved
again that temperature was a very important factor for the VTR reaction.
For the study of the initial oxygen concentration effect, unlike the Lei’s
study (Lei, et al. 2007), there was a measurable difference of GEM removal
between the observed results according to the trials #3 and #5. [Note. In all
reactions in this thesis, the laboratory VTR was pressurize with breathing air that
served as the source of oxygen for the WAO process.] While there is a 2%
decrease in oxidation of GEM, it is not clear what factor in the WAO process
contributed to this observed decrease.

Trial

GEM
(ppm)

TX-100 Time
(ppm) (min)

Oxygen
(psi)

Mean GEM
Oxidation %

Mean TX-100
Oxidation %

1

40

-

10

350

71.6

-

2

-

1,000

10

350

-

90.1

3

40

1,000

10

350

79.9

32.8

4

40

1,000

30

350

90.2

40.4

5

40

1,000

10

400

77.8

32.3

6

40

2,000

10

350

71.4

37.5

Table 3.1 Influence of the oxidation result of the gemfibrozil and surfactant on
pre-concentration factor, retention time (Rt) and initial oxygen pressure

B. Formic acid
The WAO process would ideally produce carbon dioxide and water as final
products after complete oxidation of organic matter. However, in sub-critical
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WAO systems, the reaction produces some organic by-products, which are
resistant to some extent to further oxidation, like small molecular weight acids
(acetic, formic, oxalic acids) (Zalouk, et al. 2009). Recall in section 3.3.3 that the
results had also shown that formic acid was one of the acidic products. In this
section, a study to evaluate the effect of additional formic acid added prior to the
WAO process is described.
Aqueous GEM samples, without the presence of surfactant, precipitated
when the formic acid was added into this system. This is because GEM has a very
low solubility in acid solution (0.0019 %), and when formic acid was added to the
solutions, the pH of the solution dropped below the pKa of GEM resulting in the
formation of the unionized (and thus most hydrophobic) form of GEM. Micelles
formed by surfactant could then solubilize the GEM in these acidic environmental
conditions. Hence, in order to introduce formic acids into the system, all the
experiments in this portion of the research were performed in the presence of
Triton X-100 (1,000 ppm).
Triton present in the solution was analyzed after oxidation of each sample.
Figure 3.9 shows that the origin sample without any acid produced 0.26 mM
formic acid after the WAO, which supported the research reported by others that
formic acid was indeed one of the organic by-products of WAO. Notice that the
two low values of formic acid concentration (0.63, 0.77mM) corresponded to the
samples containing the high proportion of formic acid (1.6, 2.6 mM), which could
be interpreted that most of the formic acids were reacted by the oxidation process.
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To study whether the reacted formic acids were used for the removal of
GEM, the GEM removal results were compared between samples with and without
adding formic acid into the system. As the shown in Table 3.2, the removal results
are 79.9, 65.2, 61.6 and 74.4 % for the presence 0, 1.6, 2.6 and 5.2 mM of formic
acid, respectively. Instead of achieving a better removal result, there is a decrease
in removal efficiency after adding the formic acid into system. Hence, even
through the added formic acids were consumed by WAO, it doesn’t help improve
the GEM removal efficiency. It should be noted that at the highest formic acid
concentration (5.2 mM), the removal efficiency of GEM has increased with respect
to the other formic acid solutions, although it is still lower than the GEM solution
without any formic acid. No clear explanation for these observations can be made;
thus, further research is needed to determine why these observations were found.

#

GEM
(ppm)

TX-100
(ppm)

Formic Acid
(mM)

Mean Gem
Oxidation %

1

40

-

1.6

Precipitated

2

40

1,000

-

79.9

3

40

1,000

1.6

65.2

4

40

1,000

2.6

61.6

5

40

1,000

5.2

74.4

Table 3.2 Influence of formic acid on the gemfibrozil oxidation result
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Figure 3.9 RPLC analysis of formic acid production of 40 ppm GEM
with 1,000 ppm TX-100 before and after the wet-air oxidation
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C. Sucrose
Generally, organics degradation by WAO were recognized as a free-radical
mechanism (Li, Chen and Gloyna 1991), and hydroxyl radical is an extremely
potent oxidizing agent with a short life which is able to oxidize organic
compounds and generate other free radicals in the presence of organic compounds.
Thus, in the WAO system, the reaction intermediates, especially the organic
radicals increased, accelerate the speed of the reaction with the help of dissolved
oxygen (Lei, et al. 2007). In other words, additional organic matters could help
increase the rate of oxidation reaction. The study reported in this section evaluates
the impact of adding sucrose as one type of organic matter to the 40 ppm GEM
original solution system to explore whether sucrose could help GEM removal.
All the experiments completed in the sucrose studies were performed at identical
temperature, reaction time and breathing air pressure; the only difference in these
tests was an increasing amount of sucrose was added to the samples. All tests were
performed in triplicate. The GEM removal results with different amount of sucrose
are presented in Figure 3.10. From the starting point, the sample without any
added sucrose has a removal efficiency of 71.6 %. For the samples with 500,
1,000, 2,000 and 4,500 ppm concentration of sucrose, the GEM removal efficiency
increased to 85.5, 90.6, 95.0 and 95.5 %, respectively. The results also show that
the removal efficiencies for GEM removal are quite similar for the 2,000 and
4,500 ppm samples. The oxidation did not improve significantly after adding more
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Figure 3.10 Additional sucrose dependence of the GEM removal during WAO of the 40
ppm standard solution (T=260 °C, P=350 psi, Rt=10min)
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than 2 grams of sucrose, possibly indicating that no more oxidizable organic
matter remained in the reactor or that the added oxidant (oxygen from the
breathing air) was either depleted or not at a sufficient enough concentration for
the WAO to proceed. The addition of sucrose to the gemfibrozil solution, however,
does significantly influence the GEM oxidative efficiency by producing certain
intermediates presumably, thus increasing the speed of the reaction.
All of the BR and AR samples in this study were run by METHOD 3 to
determine the qualitative and quantitative properties of acids that were produced
by wet-air oxidation. One of the major products found was formic acid, and the
concentration was quatified by using a formic acid calibration curve. These results
are presented in Figure 3.11. In general, the more sucrose that was added into the
solution, the more formic acid was produced. This resulted in a higher removal
efficiency for the WAO process. Based on these formic acid studies and those
studies reported in the previous section, an intermediate formic acid was found to
be advantageous for treating the GEM wastewater, however, adding the formic
acid directly into wastewater may not be a good help for removal reaction since
GEM will precipitate. Hence, formic acid is one of the important acidic products
by WAO that has the significant effect to the degradation of organic matters.
Further research about its reaction mechanism is planned.
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Figure 3.11 The sucrose dependence of the formic acid production of the 40 ppm sample
(#1 Sample with no sucrose; #2 Sample with 500 ppm sucrose; #3 with 1,000 ppm
sucrose; #4 with 2,000 ppm sucrose; #5 with 4,500 ppm sucrose)
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3.3.5 RESIDUE STUDY
The design of the test reactor for the WAO process makes it susceptible to
sample loss, especially when samples are sparingly soluble and present at low
concentrations (ppm and below). Residual liquids can adhere in many portions of
the piping systems in the laboratory VTR. While these low-flow areas would most
likely be engineered correctly in a full-scale version of the VTR, these areas can
potential skew the results from the WAO test using the laboratory VTR. All of the
removal results discussed in the previous sections were based on the differences
between the BR and AR, without taking into account portions of the drugs that
might have stuck to the transfer piping and resided in unreacted liquids that stick
or do not make it to the reactor vessel for treatment after entering the sample flask.
To obtain the most accurate removal efficiency of the GEM, this section describes
the procedure developed to quantify any unreacted compounds.
The first experiment of this residue study aims to determine whether there
is drug residue in the system after discharging the reacted sample from the reactor.
Methanol (200 ml) was slowly poured into the sample vessel and pumped into the
reactor instead of cleaning the reactor using water. Methanol was used because the
organic solubility of GEM is much higher in methanol than in water; thus the
methanol would help dissolve the adherent GEM on the surfaces in the test reactor.
Once the methanol was added, the reactor was operated with the rotation of reactor
for 10 min to sufficiently rinse the inside. After discharging and collecting the
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methanol, the same RPLC method was performed to quantify the mass of GEM
residue.
Assuming that GEM does not stick on the surface of the system and has
been discharged without any residue, the concentration of GEM in the methanol
should be zero. However, the analysis showed that the methanol sample
concentration was 2.68 ppm (for the sample of 40 ppm GEM) and 3.47 ppm (for
40 ppm GEM with surfactant micelle) concentration of GEM. In other words, the
average GEM residues were 6.7 % (40 ppm GEM) and 8.7 % (40 ppm GEM with
surfactant micelle). Hence, some drugs did adhere on surface of the entering pipe
and the reactor.
The second experiment was conducted to determine the location where the
6.7 % of GEM residues where mainly adhering to the surfaces of the laboratory
reactor. There are two possible situations: the transfer piping and/or the reactor.
The regular 40 ppm GEM sample was charged into the VTR system with the same
procedures as above. However, the difference of this trial was to rotate the vertical
tube for 6 min without heating after charging 350 psi breathing air pressure into
the reactor. Table 3.3 shows the analysis results of BR and AR samples. For all of
these trials, ARs have lower concentration than BRs (37.40 < 35.57; 37.86 <
35.57; 38.37 < 36.41), which means that 5.4 % of drug was lossed when the
sample was pumped into the reactor. Since the total GEM loss is 6.7 %, the
residues in the transfer piping were concluded to be the main source of drug loss.
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Sample Before

Sample After
GEM
Loss

Trial

Peak
Area
mAU*s

Concentration
ppm

Peak Area
mAU*s

Concentration
ppm

1

1043.14

37.40

991.92

35.57

4.9%

2

1055.87

37.86

992.18

35.57

6.0%

3

1070.26

38.37

1015.52

36.41

5.1%

GEM
Average
Loss

5.4%

Table 3.3 GEM concentrations before and after going through the VTR system

The final part of residue study is to prove the result of the second
experiment that the transfer piping is the main source that results in the drug loss.
First, a 40 ppm GEM sample was processes with the procedure described in
section 3.2.2. When discharging the sample from the reactor, instead of collecting
one AR sample, the effluent liquid was separated into four parts, in approximately
the portion shown in Figure 3.12. The first two samples are both small portions
(AR1 and AR2), followed by the largest portion (AR3), and the end part came out
with mixed pressure (AR4). Table 3.4 shows the results of GEM removal of
different portion of the effluent liquid. AR1, AR2 and AR3 had almost the same
removal rate, but for the AR4, there was an obvious removal efficiency result that
was very low (13.05 %). The effluent sample came at the end represents the
particles that adhered on the transfer piping, as shown in the blue circle in Figure
3.12. This experiment also proved that most of the GEM loss occurred on surfaces
associated with the transfer piping between the sample flask and the reactor vessel.
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Figure 3.12 Approximate portion of effluent liquid
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Because of the 5.4 % GEM loss in the transfer piping, all of the results
obtained above should be altered. In the results of sucrose study, for example, all
of the BR samples were named as “40 ppm sample”. Since the experimental error,
the real concentrations of BR samples made were between 37.79 to 40.03 ppm (see
Table 3.5). After the 5.4 % GEM loss caused by pumping, the concentrations of
BR samples that in the reactor decreased to the range of 35.56 – 37.87 ppm. Thus,
the corrected GEM removal efficiencies, taking in account the residue effect, were
calculated, and the results are listed in Table 3.5. By adding the corrected GEM
removal efficiencies to the Figure 3.10, a new Figure 3.13 was shown. From the
Figure 3.13, the differences (within 2 %) that caused by residue effect were not
significant in the GEM studies at these concentrations (40 ppm). However, these
effects must be carefully considered when the test concentrations of compounds
are lowered in future studies.

GEM Removal
AR1

79.0%

AR2

77.9%

AR3

75.6%

AR4

13.1%

Table 3.4 The GEM removal of different portion of the effluent liquid
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BR without Residue Effect
GEM
Trial BR Concentration
Removal
ppm
%
1
40.03
71.6
2
37.59
85.5
3
37.79
90.6
4
39.82
95.0
5
37.91
95.5

BR with Residue Effect
GEM
BR Concentration
Removal
ppm
%
37.87
70.0
35.56
84.7
35.75
90.0
37.67
94.7
35.86
95.2

Table 3.5 Concentration of BR with its removal efficiency by the consideration
of residue effect

Figure 3.13 Additional sucrose dependence of the GEM removal of the 40 ppm standard
solution with respect of residue effect
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3.4 CONCLUSIONS
Wet-air oxidation is capable of removing the concentration of 40 ppm
GEM in pure water (solutions with minimal added organic matter) with a removal
efficiency of 71.6 %. To achieve better removal efficiencies, this chapter describes
the impact of adding additional organic matter to the solution system prior to the
treatment. The non-ionic surfactant, TX-100, helped to increase the solubility of
GEM in pure water, thus improving the efficiency of VTR reaction. The additional
of formic acid, both alone and in combination with TX-100, did not give any
obvious differences for the final removal results even though it is one of the major
products of WAO. During all these studies of organic matters, sucrose was the
organic matter source that demonstrated an increase in the reaction efficiency. The
highest removal efficiency (95.5 %) is achieved when adding more that sucrose
concentration in the solution was 4,500 mg/L.
This chapter also discussed the drug residue effect on the calculate removal
efficiency from the laboratory test reactor. It was determined that, due to the
interaction of GEM with the reactor piping system, most of the GEM loss occurs
do to when the house air is pumping the sample into the reactor. However, this loss
could be accounted for with blank samples, and the overall removal efficiency
GEM by WAO can be corrected.
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CHAPTER 4 CONCLUSIONS AND FUTURE DIRECTIONS
The use of wet-air oxidation system for the pharmaceutical removal has
proven to be effective degraded representative drugs in surrogate wastewaters.
Specifically, the WAO process has a removal efficiency of 91.0 % for TMP and
95.5 % for GEM. The higher efficiencies were obtained when certain forms of
organic matter (sucrose) were used in the reaction process, and when reaction time
and temperature of the WAO process were optimized. Tables 4.1 and 4.2
summarized the TMP and GEM removal efficiencies of WAO compared with the
reported results from other previous chemical and biological techniques. The
results summarized here demonstrate that wet-air oxidation can achieve equal or
even higher removal efficiencies in the removal of the test compounds when
compared with the other wastewater treatment techniques. Thus, wet-air oxidation
can be the promising technology to remove the persistent pharmaceutical
pollutants from wastewaters.
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Treatment Technology
Biological

Removal %

Membrane bioreactor

55-86[1]

Montmorillonite KSF & K10

20-25[2-3]

Carbon black

16[4]

Ozonation

90[5]

Ferrate(VI)

100[6]

Mn(VII)

74-80[7]

TiO2/UV

80[8]

Wet air oxidation

85-92

Chemical

Table 4.1 Removal results of TMP by WAO compared with previous techniques
[1] Schröder, et al. 2012
[2] Bekçi, Seki and Yurdakoc 2006
[3] Bekçi, Seki and Yurdakoc 2007
[4] Dominguez-Vargas and Carrillo-Perez 2012
[5] Dodd, Kohler and Gunten 2009
[6] Anquandah, et al. 2011
[7] Hu, Martin and Strathmann 2010
[8] Ryan, Tan and Arnold 2011

Treatment Technology
Biological

Chemical

Removal %

Australia STPs

15-90[9]

Swedish WWTPs

32[10]

Bacterial community

36[11]

Peracetic acid

< 75[12]

Chlorine dioxide

90[12]

Wet air oxidation

72-96

Table 4.2 Removal results of GEM by WAO compared with previous techniques
[9] Ying, Kookanab and Kolpin 2009
[10] Falås, et al. 2012
[11] Caracciolo, et al. 2012
[12] Hey, et al. 2012
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Since this work represents a simulation of the treatment of residual
pharmaceuticals in wastewater, however, further work must be accomplished to
determine whether this treatment technology is effective under actual conditions.
Thus, future work in this research area is needed. Specific experiments that are
needed are detailed below.
First, the degradation of the pharmaceuticals in the real aquatic ecosystems
depends on a variety of factors, including not only the compound's properties, but
also other environmental factors, the presence of natural microbial communities
(Gros, Petrović and Barceló 2007, Onesios, Yu and Bouwer 2009). All of these
environmental factors should be considered as important removal effects. More
importantly, the removal of these compounds should be accomplished using actual
sewage to determine the effectiveness of the WAO process under operation
conditions as close as possible to the proposed use of this technology.
Second, a broader evaluation of the impact of the type of organic matter
used in the WAO process needs to be conducted. Preliminary results from other
members of the research group indicate that certain compounds produce higher
percentages of formic acid per carbon atom. Based on the results presented in
Chapter 3, formic acid appears to have a positive correlation to the degradation of
these drugs.
Third, it is necessary to better understand the degradation mechanisms of
these two pharmaceuticals so that to develop the most optimal operation. Formic
acid, as one of the key products of WAO, plays an important role in the entire
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removal reaction. How does it work and what is its mechanism during the entire
reaction? The subsequent analysis of mass spectrometry and ion chromatography
would be probably helpful to solve these questions.
Finally, while the degradation of the target pharmaceuticals has been
demonstrated in this work, degradation products, in addition to the simple organic
acids like formic and acetic acid were produced. Presently, the chemical identity
of these compounds is not known. Thus, future experiments must also focus on
determining the identity of the degradation products.
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